These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9386806)

  • 1. Cytomegalovirus (CMV) retinitis and CMV antigenemia as a clue to impaired adrenocortical function in patients with AIDS.
    Hoshino Y; Nagata Y; Gatanaga H; Hosono O; Morimoto C; Tachikawa N; Nomura K; Wakabayashi T; Oka S; Nakamura T; Iwamoto A
    AIDS; 1997 Nov; 11(14):1719-24. PubMed ID: 9386806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the cytomegalovirus (CMV)-antigenemia assay as a predictive and follow-up detection tool for CMV disease in AIDS patients.
    Hoshino Y; Nagata Y; Taguchi H; Masunaga A; Fujino Y; Mochizuki M; Nakamura T; Iwamoto A
    Microbiol Immunol; 1999; 43(10):959-65. PubMed ID: 10585142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of cytomegalovirus (CMV)-pp65 antigenemia in the diagnosis of CMV disease in human immunodeficiency virus-infected patients.
    Reynes J; Montes B; Atoui N; Segondy M
    J Med Virol; 1996 Jul; 49(3):195-8. PubMed ID: 8818964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of pp65 antigenemia for the early diagnosis of cytomegalovirus disease in patients with AIDS.
    Torrús D; Portilla J; Hernández-Aguado I; Boix V; Plazas J; Gimeno A; Torromé M; Llopis C; Valls V; Sánchez-Payá J
    Eur J Clin Microbiol Infect Dis; 1999 Sep; 18(9):630-5. PubMed ID: 10534184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
    Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
    Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pp65 antigenemia as a marker of future CMV disease and mortality in HIV-infected patients.
    Podzamczer D; Ferrer E; García A; Ramón JM; Niubó J; Santín M; Rufí G; Pérez JL; Martín R; Gudiol F
    Scand J Infect Dis; 1997; 29(3):223-7. PubMed ID: 9255879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMV pp65 antigen testing is of limited utility in the diagnosis of concomitant CMV disease in HIV-infected patients in the HAART era.
    Skiest DJ; Crosby C
    J Clin Virol; 2003 Oct; 28(2):203-13. PubMed ID: 12957190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative CMV antigenemia correlated with ophthalmoscopic screening for CMV retinitis in AIDS patients.
    Fezza J; Weitzman M; Shoemaker D; Gremillion C; Chen H
    Ophthalmic Surg Lasers; 2001; 32(1):81-2. PubMed ID: 11195751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the cytomegalovirus (CMV) antigenemia assay for predicting the occurrence of CMV disease and death in patients with AIDS.
    Chevret S; Scieux C; Garrait V; Dahel L; Morinet F; Modaï J; Decazes JM; Molina JM
    Clin Infect Dis; 1999 Apr; 28(4):758-63. PubMed ID: 10825035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing cytomegalovirus disease in CMV seropositive renal allograft recipients: a comparison between the detection of CMV DNAemia by polymerase chain reaction and antigenemia by CMV pp65 assay.
    Lo CY; Ho KN; Yuen KY; Lui SL; Li FK; Chan TM; Lo WK; Cheng IK
    Clin Transplant; 1997 Aug; 11(4):286-93. PubMed ID: 9267717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of cytomegalovirus-matrix protein (pp65) in leukocytes of HIV-infected patients with painful peripheral neuropathy.
    Mastroianni CM; Sebastiani G; Folgori F; Ajassa C; Vullo V; Volpi A
    J Med Virol; 1994 Oct; 44(2):172-5. PubMed ID: 7852958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a quantitative cytomegalovirus (CMV) antigenemia test in evaluating HIV+ patients with and without CMV disease.
    Wetherill PE; Landry ML; Alcabes P; Friedland G
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 May; 12(1):33-7. PubMed ID: 8624758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of three assays for cytomegalovirus detection in AIDS patients at risk for retinitis.
    Wattanamano P; Clayton JL; Kopicko JJ; Kissinger P; Elliot S; Jarrott C; Rangan S; Beilke MA
    J Clin Microbiol; 2000 Feb; 38(2):727-32. PubMed ID: 10655375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal pigment epithelial dysfunction in human immunodeficiency virus-infected patients with cytomegalovirus retinitis.
    Harrison JM; van Heuven WA
    Ophthalmology; 1999 Apr; 106(4):790-7. PubMed ID: 10201604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation.
    Ksouri H; Eljed H; Greco A; Lakhal A; Torjman L; Abdelkefi A; Ben Othmen T; Ladeb S; Slim A; Zouari B; Abdeladhim A; Ben Hassen A
    Transpl Infect Dis; 2007 Mar; 9(1):16-21. PubMed ID: 17313466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus pp65 antigenaemia as an indicator of end-organ disease in AIDS.
    Fox EF; Smith NA; Rice P; Dunn H; Peters BS
    Int J STD AIDS; 1998 Sep; 9(9):545-7. PubMed ID: 9764940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
    Salmon-Céron D; Mazeron MC; Chaput S; Boukli N; Senechal B; Houhou N; Katlama C; Matheron S; Fillet AM; Gozlan J; Leport C; Jeantils V; Freymuth F; Costagliola D
    AIDS; 2000 May; 14(8):1041-9. PubMed ID: 10853987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMV-antigenemia in peripheral blood for the diagnosis of CMV disease in HIV-infected patients.
    Salzberger B; Franzen C; Fätkenheuer G; Cornely O; Schwenk A; Rasokat H; Diehl V; Schrappe M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):365-9. PubMed ID: 8601222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial.
    Jabs DA; Gilpin AM; Min YI; Erice A; Kempen JH; Quinn TC;
    AIDS; 2002 Apr; 16(6):877-87. PubMed ID: 11919489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.